Samsung Medical Center
Bladder cancer treatment cost in South Korea typically starts with essential diagnostics like a PET/CT scan running AUD $1,445 to AUD $2,167. Primary surgical interventions, such as bladder removal, generally cost between AUD $26,726 and AUD $51,286. Total expenses depend on the cancer stage and hospital tier, though Australians typically save 30–60% compared to US and Australian private healthcare rates. Top cities for these procedures include Seoul and Incheon.
Typical Bladder Cancer Treatment Costs in South Korea
Bookimed Expert Insight: For complex cases, choosing a multidisciplinary hub like Asan Medical Center is vital. They handle over 2,500 inpatients daily, providing high surgical experience. Patients focused on precision may prefer robotic surgery packages at Seoul St. Mary’s Hospital. These start around A$49,700 and include hospital stays. Budget-conscious travellers should consider Incheon-based clinics like Gachon University Gil Medical Center for competitive rates.
| Republic of Korea | Thailand | Turkey | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $33,950 | from AUD $43,340 | from AUD $32,505 |
| Chemotherapy for breast cancer | from AUD $27,738 | from AUD $4,334 | from AUD $1,734 |
| Bladder removal | from AUD $26,726 | from AUD $17,336 | from AUD $11,557 |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $7,512 | from AUD $11,557 | from AUD $4,767 |
| Radiation therapy for colorectal cancer | - | from AUD $7,946 | from AUD $10,113 |
No hidden fees – just official clinic prices. Pay at the clinic for Bladder cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Bladder cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Bladder cancer treatment journey.
Professor Choi Han Yong is the former Head of Urology at Samsung Medical Center – one of South Korea's most technologically advanced hospitals.
Dr. Son Dong Wan serves as the Chief of Urology at Naeun Hospital. He specializes in laser prostate surgery and robotic procedures for urologic cancers. He received the Best Poster Award from the European Association of Urology. Dr. Son earned his PhD from Pusan National University.
Professor Won Sik Ham serves as a senior urologist and oncosurgeon at Severance Hospital, specialising in surgical management for bladder malignancies.
Professor Koon Ho Rha is a global leader in robotic urology at Severance Hospital – home to Asia's first and largest robotic surgery centre.
The Republic of Korea offers specialised bladder cancer treatments. These include immunotherapy with pembrolizumab and robotic radical cystectomy. Leading Seoul centres use Da Vinci systems and image-guided radiation therapy (IGRT). Multidisciplinary teams at JCI-accredited hospitals provide systemic chemotherapy and diagnostics for metastatic cases.
Bookimed Expert Insight: South Korea distinguishes itself through digital integration in oncology. Seoul National University Bundang Hospital uses the BESTcare system to reduce medical errors. This infrastructure allows precise tracking of chemotherapy cycles. It also allows for seamless data sharing with Australian GPs. Such technical precision often results in more reliable outcomes for staged metastatic protocols.
Patient Consensus: Patients value multidisciplinary centres that combine oncology, urology, and imaging. Many suggest checking that the facility offers clear English coordination. They also recommend having structured follow-up plans before returning to Australia.
South Korea is a global leader in robot-assisted bladder cancer surgery. Major Seoul hospitals use the Da Vinci system for complex radical cystectomy and neobladder reconstruction. Centres such as Korea University Anam Hospital performed Asia's first successful robotic pre-stage bladder surgeries. Highly skilled urologists perform these procedures through small incisions.
Bookimed Expert Insight: Korea University Anam Hospital pioneered Asia's first robotic pre-stage bladder cancer surgery. Many centres use robots for general urology. However, this facility specifically focuses on robotic techniques that reduce visible scarring. Patients should prioritise surgeons like Dr Koon Ho Rha who specialise in robotic oncological surgery for better precision.
Patient Consensus: Patients emphasise focusing on a surgeon's specific case volume for bladder removals. They suggest looking at this rather than just the hospital's robotic equipment. They also note it is important to confirm local follow-up arrangements before travelling. Patients should also check the urinary diversion options available in South Korea.
Standard treatment for non-muscle invasive bladder cancer in South Korea starts with transurethral resection. Surgeons remove tumours through the urethra using cystoscopes. Patients then receive intravesical therapy, where medication enters the bladder directly. This prevents recurrence and treats early-stage cases in Seoul centres.
Bookimed Expert Insight: South Korean oncology centres like Samsung Medical Center and Severance Hospital handle immense patient volumes. Severance alone treats 4,000,000 patients annually. This scale means urologists manage early-stage bladder cancer with high technical proficiency. Clinics here often use digital health systems like BESTcare to minimise medical errors during complex drug protocols.
Samsung Medical Center, Severance Hospital, and Seoul National University Hospital are top South Korean centres for bladder cancer. These JCI-accredited facilities offer robotic cystectomy and artificial bladder reconstruction. Specialists use the da Vinci surgical system to remove tumours with high precision. This often helps to preserve bladder function.
Bookimed Expert Insight: Korea University Anam Hospital provides a distinct advantage for early-stage patients. It was the first in Asia to perform pre-stage robotic surgery for bladder cancer. Their focus on bloodless techniques and minimal transfusions helps reduce infection risks. This expertise supports faster recovery times compared to traditional open surgery methods.
Australian patients receive comprehensive English-language support for bladder cancer treatment in South Korea. Major JCI-accredited hospitals in Seoul provide dedicated international centres with medically trained interpreters. These facilities manage English documentation, logistics, and consultations for clear communication during complex oncology procedures.
Bookimed Expert Insight: Most major Seoul hospitals offer translation. However, Korea University Anam Hospital stands out for urological innovation. It performed Asia's first successful robot-assisted pre-stage bladder cancer surgery. Patients choosing specialised centres benefit from teams used to explaining complex robotic techniques to international patients in English.
Patient Consensus: Patients note that communication is smoothest at international desks in Seoul. They recommend confirming an English-speaking coordinator's name before arrival. This helps with ward-level care and discharge instructions.
Bladder cancer surgery in South Korea usually starts within 14 days of the initial diagnosis. Major Seoul centres prioritise urgent muscle-invasive cases and often start treatment within 3 to 7 days. Specialists aim for radical cystectomy within 56 days for optimal survival outcomes.
Bookimed Expert Insight: Korea University Anam Hospital was an early adopter of robotic bladder surgery in Asia. Using the Da Vinci system often allows surgeons to schedule complex reconstructions sooner. This can bypass the longer queues found in general surgical departments at regional hospitals.
Patient Consensus: Patients recommend asking for a written timeline before travelling from Australia. They also suggest classing the case as urgent. It is important to confirm if delays stem from pre-operative tests or surgeon availability.